Go to deals
Healthcare

Väsby Läkargrupp has been acquired by Doktor.se

The shareholders of Väsby Läkargrupp have sold the company to Doktor.se.

Väsby Läkargrupp is a healthcare provider offering primary care, occupational health care and vaccinations through a clinic located in Upplands Väsby in Sweden. The company was founded in 1987 and has approximately 45 employees.

Doktor.se is a digital healthcare and technology company offering digital triage and treatment through its digital healthcare platform as well as through physical clinics in Sweden. The company was founded in 2016 and is one of Sweden’s leading digital healthcare providers.

Oaklins’ team in Sweden acted as financial advisor to the sellers in this transaction.

Parties

Talk to the deal team

Anders Ingler

Senior Advisor
Stockholm, Sweden
Oaklins Sweden

Lars Gustafsson

Partner
Stockholm, Sweden
Oaklins Sweden

Christos Karabelas

Associate Director
Stockholm, Sweden
Oaklins Sweden

Related deals

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market
Financial Services | Healthcare

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Learn more
Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more